Biogen Idec director sells 15,000 shares

By
A A A

Bobby Raines 01/10/2014

William Young, a director at Biogen Idec ( BIIB ) sold 15,000 shares of the company's common stock on Jan. 8. At $285.11 per share, Young pulled in a total of $4,276,590 from the sale.

IK-> The technicals for BIIB ($289.71 down $0.04) are bullish with a neutral trend. Recent support has been around $271.17 and recent resistance has been around $296.40. Standard & Poor's has a three STARs (out of five) rating the stock. Look at the Feb. 325/330 bear-call spread for a 30-cent credit. That's a 6.38% return and the stock has to rise 12.2% to cause a problem.  [InvestorsKeyhole, Various news and data services]




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Originally published on InvestorsObserver.com


This article appears in: Investing , Options

Referenced Stocks: BIIB

InvestorsObserver

InvestorsObserver

More from InvestorsObserver:

Related Videos

Don't Pay Up to Play REITs
Don't Pay Up to Play REITs          

Stocks

Referenced

Most Active by Volume

100,376,898
  • $17.62 ▲ 0.51%
83,231,837
  • $25.62 ▲ 1.91%
75,739,329
  • $111.78 ▼ 0.77%
65,297,937
  • $36.37 ▼ 1.76%
59,053,093
  • $47.66 ▲ 0.29%
53,482,350
  • $2.59 ▼ 0.38%
51,504,284
  • $7.34 ▲ 2.37%
51,434,656
  • $8.14 ▲ 6.96%
As of 12/19/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com